Search Results for keywords:"rare pediatric diseases"

Search Results: keywords:"rare pediatric diseases"

H. R. 3433 — To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
September 20, 2024
Status:Reported in House
Congress:118
Words:5,960
H. R. 3433, known as the "Give Kids a Chance Act of 2024," aims to amend the Federal Food, Drug, and Cosmetic Act to improve the investigation of drugs for pediatric cancer by requiring specific targeted studies and enhancing FDA authority. It also extends the priority review voucher program...
Simple Explanation
The "Give Kids a Chance Act of 2024" is like making a new rulebook to help find better medicines for kids with cancer, making sure everyone involved works together nicely, and keeping everyone honest about sharing important findings.
S. 4583 — To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.
June 18, 2024
Status:Introduced in Senate
Congress:118
Words:261
S. 4583, known as the “Creating Hope Reauthorization Act of 2024,” aims to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers. These vouchers are used to encourage the development of treatments for rare pediatric diseases. The...
Simple Explanation
The bill wants to let a special group keep giving out golden tickets, called "priority review vouchers," to help make medicines for kids with rare sicknesses. This special permission was supposed to end in 2024, but the bill wants to make it last until 2030.
H. R. 7384 — To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.
February 15, 2024
Status:Introduced in House
Congress:118
Words:284
H.R. 7384, known as the “Creating Hope Reauthorization Act of 2024,” is proposed legislation that seeks to amend the Federal Food, Drug, and Cosmetic Act. It aims to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers, which...
Simple Explanation
H.R. 7384 is a law idea to keep giving special prizes called "priority review vouchers" to companies that make important medicines for kids with rare sicknesses until 2028, and maybe a bit longer if needed.

Showing 1 to 3 of 3 results